IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression

Human Reproduction

Volumn 20, Issue 9, 2005, Pages 2441-2447

  Bjercke, Sverre ^a   Fedorcsak, P ^a   Abyholm T ^a   Storeng, R ^a   Ertzeid, G ^a   Oldereid, N ^a   Omland, A ^a   Tanbo, T ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Assisted reproduction; Early pregnancy loss; FSH; LH; Ovarian stimulation

Indexed keywords

GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONCEPTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVULATION INDUCTION; OVULATION INHIBITION; PREDICTION; PREGNANCY COMPLICATION; RECEIVER OPERATING CHARACTERISTIC; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 24044495895     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/dei101     Document Type: Article

References (36)

1. Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca JL, Puerto B and Vanrell JA (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a women with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 10, 1678-1683.
2. Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, Fabregues F and Vanrell JA (2001) Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 16,1636-1643.
3. Bernhart K, Dunsmoor-Su R and Coutifaris C (2002) Effect of endometriosis on in vitro fertilization. Fertil Steril 77,1148-1155.
4. Ben-Chetrit A, Gotlieb L, Wong PY and Casper RF (1996) Ovarian response to recombinant human follicle stimulating hormone in luteinizing hormone-depleted women: Examination of the two cell, two gonadotropin theory. Fertil Steril 65,711-717.
5. Carbrera RA, Stadtmauer L, Mayer JF, Gibbons WE and Oehninger S (2005) Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotrophin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Fertil Steril 83,42-48.
6. Chappel SC and Howles CM (1991) Re-evaluation of the roles of luteinizing hormone and follicle stimulating hormone and follicle stimulating hormone in the ovulatory process. Hum Reprod 6,1206-1212.
7. Cortvrindt R, Hu Y and Smitz J (1998) Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant folicle stimulating, hormone-supplemented mouse preantral follicle stimulating hormone-supplemented mouse preantral follicle culture. Hum Reprod 13,1292-1302.
8. Dada T, Salha O, Baillie HS and Sharma V (1999) A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: A prospective randomized study. Hum Reprod 14,288-293.
9. Dale PO, Tanbo T, Haug E and Abyholm T (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod 13,567-570.
10. Daya S, Gunby J, Hughes EG, Collins JA and Sagle MA (1995) Follicle stimulating hormone versus human meopausal gonadotrophin for in vitro fertilization cycles: A meta-analysis. Fertil Steril 64,347-354.
11. European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: A dose-finding study. J Clin Endocrinol Metab 85,1507-1514.
12. Fevold HL (1941) Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 28,33-36.
13. Flemming R and Coutts JR (1986) Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 45,226-230.
14. Flemming R, Iloyd F, Herbert M, Fenwick J, Griffiths T and Murdoch A (1998) Effects of profound suppression of luteinizing hormone during ovarian stimulation on follilicular activity, oocyte and embryo function in cycles stimulation with purified follicle stimulation hormone. Hum Reprod 13,1788-1792.
15. Flemming R, Rehka P, Deshpande N, Jamieson ME, Yates RW and Lyall H (2000) Suppression of LH during ovarian stimulation: Effects differ in cycles stimulated with purified urinary purified urinary FSH and recombinant FSH. Hum Reprod 15,1440-1445.
16. Fox R, Ekeroma A and Wardle P (1997) Ovarian response to purified FSH in infertile women with long-standing hypogonadotropic hypogonadism. Aust NZ J Obstet Gynecol 37,92-94.
17. Janssens RMJ, Lambalk CB, Wermeiden JPW, Schats R, Bernards JM, Rekers-Mombarg LT and Schoemaker J (2000) Dose finding study of triptorelin acetate for prevention of a premature LH surge in IVF: A prospective, randomized, double-blind, placebo-controlled study. Hum Reprod 15,2258-2265.
18. Humaidan P, Bungum L, Bungum M and Yding Andersen C (2002) Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 8, 2016-2021.
19. Hanley JA and McNeil BJ (1982) The meaning of the use of the area under receiving operating characteristic (ROC) curve. Radiology 143,29-36.
20. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA and Giudice LC (2003) Expression profiling of endometrium from women with endometriosis reveals candidate genes for diseasebased implantation failure and infertility. Endocrinology 144, 2870-2881.
21. Kousta E, White DM, Piazzi A, Loumaye E and Franks S (1996) Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallman's syndrome. Hum Reprod 11,70-71.
22. Lisi F, Rinaldi L, Fishel S, Caserta D, Lisi R and Campbell A (2005) Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 83,309-315.
23. Lockwood GM, Pinkerton SM and Barlow DH (1995) A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod 10,293-298.
24. Loumaye E, Engrand P, Howles CM and O'dea L (1997) Assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 67,889-899.
25. Ryan KJ, Petro Z and Kaiser J (1968) Steroid formation by isolated and recombined ovarian granulosa and thaca cells. J Clin Endocrinol Metab 28,355-358.
26. Schoot DC, Coelingh Bennink HJ, Mannaerts BM, Lamberts SW, Bouchard P and Fauser BC (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a women with isolated gonadotrophin deficiency. J Clin Endocrinol Metab 74,1471-1473.
27. Shoham Z (2002) The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 77,1170-1177.
28. Shoham Z, Balen A, Patel A and Jacobs HS (1991) Results of ovulation induction using human menopausal gonadotropins or purified follicle-stimulating hormone in hypogonadotrophic hypogonadism patients. Fertil Steril 56,1048-1051.
29. Simberg N, Tulppala M, Husa LM and Tiitinen A (1998) Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles. Acta Obstet Gynecol Scand 77,854-859.
30. Surrey ES, Silverberg KM, Surrey MW and Schoolcraft WB (2002) Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 78,699-704.
31. Tanbo T, Dale PO, Lunde O, Norman N and Abyholm T (1992) Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 57,819-824.
32. Tanbo T, Dale PO and Åbyholm T (2001) Recombinant follicle-stimulating hormone stimulates ovarian androgen synthesis in down-regulated ovulatory women. Gynecol Endocrinol 15,407-412.
33. Westergaard LG, Erb K, Laursen SB, Rasmussen PE and Rex S (1996) The effect of human menopausal gonadotrophin and highly purified urinederived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod 11,1209-1213.
34. Westergaard LG, Laursen SB and Yding Andersen C (2000) Increased risk of early pregnancy loss by profound suppresion of luteinizing hormone during ovarian stimulation in IVF treated normogonadotrophic women. Hum Reprod 5,1003-1008.
35. Westergaard LG, Erb K, Laursen SB and Rasmussen PE (2001) Human menopausal gonadotrophin versus recombinant follicle-stmulating hormone in normogonadotrophic women down-regulated with a gonadotrophin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study. Fertil Steril 76,543-549.
36. Zweig MH and Campell G (1993) Receiver-operating characteristic (ROC) plots: A functional evaluation tool in clinical medicine. Clin Chem 39, 561-577.